Sort
40,608 grants matching “prostate cancer”
Role of Caveolin-1 in the Maintenance of Blood-retinal Barrier Integrity
$363,250Michael H Elliott · University Of Oklahoma Hlth Sciences Ctr · R01 · FY2024 · EY
miR-205 Nanoparticle system circumvents docetaxel resistance in prostate cancer
$363,250Murali Mohan Yallapu · University Of Texas Rio Grande Valley · SC1 · FY2022 · GM
Role of Caveolin-1 in the Maintenance of Blood-retinal Barrier Integrity
$363,250Michael H Elliott · University Of Oklahoma Hlth Sciences Ctr · R01 · FY2025 · EY
P63 IN EPITHELIAL CELL PROLIFERATION AND DIFFERENTIATION
$363,219Harvard University (Medical School) · R01 · FY2001 · CA
Design of Programmable Genotoxins
$363,201John M Essigmann · Massachusetts Institute Of Technology · R01 · FY2007 · CA
Targeting m6A RNA epigenetics in treatment-emergent neuroendocrine prostate cancer
$363,164Min Sup Song · University Of Tx Md Anderson Can Ctr · R01 · FY2022 · CA
Targeting m6A RNA epigenetics in treatment-emergent neuroendocrine prostate cancer
$363,164Min Sup Song · University Of Tx Md Anderson Can Ctr · R01 · FY2023 · CA
Functional Interaction of Amyloid-b Protein with Glial Toll-Like Receptors
$363,127Michael R. Nichols · University Of Missouri-St. Louis · R15 · FY2011 · AG
CD8+ T Cell-Mediated Immunotherapy of Autochthonous SV40 T Antigen-Induced Tumors
$363,051Todd D Schell · Pennsylvania State Univ Hershey Med Ctr · R01 · FY2014 · CA
Role of U19/Eaf2 in androgen-dependent prostate homeostasis
$363,009Zhou Wang · University Of Pittsburgh At Pittsburgh · R37 · FY2013 · DK
Identification of Specific Antagonists that Bind Hedgehog and Block its Activity
$362,905Kevin Peter Williams · North Carolina Central University · R15 · FY2011 · CA
Pharmacogenetic Studies
$362,893Neil E. Caporaso · Division Of Cancer Epidemiology And Genetics · ZIA · FY2018 · CA
Project 3: Extending Clinical Benefit by Selective Treatment of Resistant Lesions in mCRPC
$362,884Robert Jeraj · University Of Wisconsin-Madison · P50 · FY2025 · CA
New protein engineering-based tools and technologies for characterizing cell surface proteolysis in cancer cells for novel neo-epitope biomarkers and drug targets
$362,803James A Wells · University Of California, San Francisco · R01 · FY2020 · CA
Consequences and mechanism of aberrant splicing in African American prostate cancer disparities
$362,798Norman H Lee · George Washington University · R01 · FY2018 · CA
Pharmacokinetic strategies to increase monoclonal antibody uptake, distribution, and efficacy for treatment of solid tumors
$362,764Joseph P Balthasar · State University Of New York At Buffalo · R01 · FY2020 · CA
Novel Herbal Medicine for the Treatment of Prostate Cancer
$362,763Chendil Damodaran · University Of Kentucky · R01 · FY2007 · AT
Project 2: Effect of HTLV-1 Viral Oncogenes on the Bone Microenvironment during tumor growth and progression in ATL
$362,735Katherine Nelson Weilbaecher · Ohio State University · P01 · FY2021 · CA
Project 3: Induction of synthetic lethality with combined DNMT and PARP inhibition
$362,734Srinivasan Yegnasubramanian · Johns Hopkins University · P50 · FY2024 · CA
Pharmacokinetic strategies to increase monoclonal antibody uptake, distribution, and efficacy for treatment of solid tumors
$362,722Joseph P Balthasar · State University Of New York At Buffalo · R01 · FY2021 · CA
Parp Function in Prostate Cancer
$362,689Bryce M Paschal · University Of Virginia · R01 · FY2019 · CA
Chemoprevention of Colon Cancer, HDAC Inhibition, and Histone Status
$362,676Roderick H Dashwood · Oregon State University · P01 · FY2012 · CA
Pooling of Prospective Studies of Diet and Cancer
$362,642Stephanie A Smith-Warner · Harvard School Of Public Health · P01 · FY2008 · CA
Training Program in Cancer Biology
$362,640Mary Elaine Reyland · University Of Colorado Denver · T32 · FY2019 · CA
Structure and Inhibition of the Conjugative DNA Relaxase-Helicase
$362,638Matthew Redinbo · Univ Of North Carolina Chapel Hill · R01 · FY2009 · AI